Results 211 to 220 of about 861,991 (266)
Some of the next articles are maybe not open access.
CRC Critical Reviews in Clinical Laboratory Sciences, 1981
(1981). Polyamines as Tumor Markers. CRC Critical Reviews in Clinical Laboratory Sciences: Vol. 16, No. 1, pp. 1-34.
James R Shipe +3 more
openaire +2 more sources
(1981). Polyamines as Tumor Markers. CRC Critical Reviews in Clinical Laboratory Sciences: Vol. 16, No. 1, pp. 1-34.
James R Shipe +3 more
openaire +2 more sources
1987
In diagnostic virology, isolation of viruses by culturing infectious material and serological immunoassays have usually met the clinical needs for: 1. accurate identification of the infectious agent, 2. definition of the state of the disease (acute, convalescence, recovery), 3.
T, Löning, K, Milde
openaire +3 more sources
In diagnostic virology, isolation of viruses by culturing infectious material and serological immunoassays have usually met the clinical needs for: 1. accurate identification of the infectious agent, 2. definition of the state of the disease (acute, convalescence, recovery), 3.
T, Löning, K, Milde
openaire +3 more sources
Seminars in Surgical Oncology, 1990
AbstractThe advent of monoclonal technology has increased the potential utility of antibody‐dependent tumor marker assays in gynecologic oncology. The availability of unlimited quantities of several pure monoclonal antibodies directed against novel epitopes on tumor‐associated antigens has permitted development of highly sensitive assays for serum ...
G J, Olt, A, Berchuck, R C, Bast
openaire +2 more sources
AbstractThe advent of monoclonal technology has increased the potential utility of antibody‐dependent tumor marker assays in gynecologic oncology. The availability of unlimited quantities of several pure monoclonal antibodies directed against novel epitopes on tumor‐associated antigens has permitted development of highly sensitive assays for serum ...
G J, Olt, A, Berchuck, R C, Bast
openaire +2 more sources
Primary Care: Clinics in Office Practice, 1992
The past decade has seen many advances in the detection, characterization, and clinical applications of tumor markers. Although cancer screening applications have been limited by low disease prevalences in asymptomatic populations, tumor markers may be of diagnostic value in specific situations.
openaire +2 more sources
The past decade has seen many advances in the detection, characterization, and clinical applications of tumor markers. Although cancer screening applications have been limited by low disease prevalences in asymptomatic populations, tumor markers may be of diagnostic value in specific situations.
openaire +2 more sources
When Is a Tumor Marker Not a Tumor Marker?
New England Journal of Medicine, 1975Almost all the biologically active protein and polypeptide hormones, including those synthesized and secreted by the normal placenta, have been implicated in ectopic humoral syndromes associated wi...
openaire +1 more source
Glycoproteins as Tumor Markers
Clinics in Laboratory Medicine, 1982Glycoproteins appear to be associated with changes in neoplastic cells, but until the intracellular role of these serum proteins and their function in cellular secretions are understood, their clinical usefulness as tumor markers will be limited.
R W, Drummond, L M, Silverman
openaire +2 more sources
Cancer Letters, 2003
Telomerase, a critical enzyme responsible for continuous cell growth, is repressed in most somatic cells except proliferating progenitor cells and activated lymphocytes, and activated in approximately 85% of human cancer tissues. Telomerase activity is a useful cancer-cell detecting marker in some types of cancers in which almost all cases show ...
Eiso, Hiyama, Keiko, Hiyama
openaire +2 more sources
Telomerase, a critical enzyme responsible for continuous cell growth, is repressed in most somatic cells except proliferating progenitor cells and activated lymphocytes, and activated in approximately 85% of human cancer tissues. Telomerase activity is a useful cancer-cell detecting marker in some types of cancers in which almost all cases show ...
Eiso, Hiyama, Keiko, Hiyama
openaire +2 more sources
Bulletin of Experimental Biology and Medicine, 2009
The main biologically significant molecular markers of human tumors are discussed on the basis of modern published data and author's findings of many-year studies: steroid hormone receptors, growth factors and underlying signal proteins, tumor-associated proteases, and angiogenesis markers.
N E, Kushlinsky +3 more
openaire +2 more sources
The main biologically significant molecular markers of human tumors are discussed on the basis of modern published data and author's findings of many-year studies: steroid hormone receptors, growth factors and underlying signal proteins, tumor-associated proteases, and angiogenesis markers.
N E, Kushlinsky +3 more
openaire +2 more sources
Minerva medica, 1984
Biological markers of tumors are compounds or enzymatic activities measurable in body fluids. Their presence or concentration must be linked to tumoral growth. The markers of the central nervous system tumors are detected in CSF. Alpha-feto-protein, carcinoembryonic antigen, human chorionic gonadotropin, adenohypophyseal peptide hormones, enzymes, etc.,
R. Fumagalli +3 more
openaire +2 more sources
Biological markers of tumors are compounds or enzymatic activities measurable in body fluids. Their presence or concentration must be linked to tumoral growth. The markers of the central nervous system tumors are detected in CSF. Alpha-feto-protein, carcinoembryonic antigen, human chorionic gonadotropin, adenohypophyseal peptide hormones, enzymes, etc.,
R. Fumagalli +3 more
openaire +2 more sources
1987
Neuroendocrine tumors arise from organs known to secrete neuroendocrine messengers, e.g. hormones or substances with paracrine activity, and/or to contain cells displaying neuroendocrine characteristics or activity. The term “neuro-endocrine” is used here to define the secretory products of the cells and tumors rather than their nature and ...
openaire +2 more sources
Neuroendocrine tumors arise from organs known to secrete neuroendocrine messengers, e.g. hormones or substances with paracrine activity, and/or to contain cells displaying neuroendocrine characteristics or activity. The term “neuro-endocrine” is used here to define the secretory products of the cells and tumors rather than their nature and ...
openaire +2 more sources